Expert Pitch

How Big a Deal is the $55 Billion Pipeline Between China and Russia? A Finance Expert at UVA's McIntire School of Commerce Weighs In

 Newswise
6-Dec-2019 12:25 PM EST, by Newswise

Zhaohui Chen is an Associate Professor of Commerce at the University of Virginia, McIntire School of Commerce.

Areas of Expertise: 

  • Finance
  • Corporate finance theory
  • Institutional and individual reputations
  • Financial contracts

 

How Big a Deal is the $55 Billion Pipeline Between China and Russia?

This is the question the world pondered as the pipeline began delivering Russian natural gas to China on Monday, Dec 2nd. China and Russia squandered no opportunities to emphasize the strengthening of their relationship. Putin called it “an absolute natural partnership” and Xi described Putin as his “closest and most intimate friend”. The Wall Street Journal on Dec 1st claimed that the pipeline “is a physical bond strengthening a new era of cooperation between the two world powers that have separately challenged the U.S.” But neither the Sino-Russian relationship nor their cooperation to challenge the U.S. is new.

China and Russia have seen much stronger relationship. The Soviet Union, the predecessor of Russia, helped founding the Chinese Communist Party (CCP) in 1921. It helped CCP winning a civil war and establishing the People’s Republic of China in 1949. After CCP became the sole ruling party of China, the Soviet Union played an essential role in industrializing China by building 156 major industrial projects in China, spanning the full spectrum of industries. Many students went to study in Russia at that time. Among them was Jiang Zemin, who later became the President of China. China and Russia were strong allies challenging the U.S. led global order in the Cold War. During the Korean War (1950-1953), the Chinese army fought the U.S. led UN army under the air support from Russian pilots. 

But the good relationship didn’t last long. China and Russia competed for control of the worldwide Communist movement after Stalin’s death. Things got so bad that there was a serious possibility of a major war between the two countries in the early 1960s and two border clashes in 1969. Their challenges to the U.S, either jointly or separately, failed too. China even joined force with the U.S. in the 1970s against Russia by invading Vietnam, an ally of Russia at that time. 

Now their common interest against U.S. seems to improve their relationship again. Both countries have a lot to gain from trading with each other and the world should welcome a stronger Sino-Russian relationship. Their cooperation to challenge the U.S. led world order however is a totally different matter. Both countries need the West in order to survive. In the Cold War, without Western technological and capital infusions, their economy collapsed on its own. China and Russia may be very different countries now, but their fundamental reliance on the West remains the same.

 

 




Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.


Showing results

110 of 4573

close
1.39431